ibuprofen and atenolol

ibuprofen has been researched along with atenolol in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (2.38)	18.7374
1990's	2 (4.76)	18.2507
2000's	15 (35.71)	29.6817
2010's	21 (50.00)	24.3611
2020's	3 (7.14)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Faller, B; Wohnsland, F	1
Caron, G; Ermondi, G	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chuang, S; Horne, J; Porter, CJ; Scanlon, MJ; Velkov, T	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W	1
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Avdeef, A; Tam, KY	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL	1
Ciancio, SG	1
Forsling, ML; Yasin, SA	1
Grahn, A; Hermansson, I; Hermansson, J	1
Bujak-Gizycka, B; Kłys, M; Latacz, B; Skupień, E	1
Grishko, VI; Oliveira, D; Tran, CD	1
Lee, Y; von Gunten, U	1
Concha-Graña, E; López-Mahía, P; Muniategui-Lorenzo, S; Prada-Rodríguez, D; Quintana, JB; Rodil, R	1
Meng, F; Xu, W	1
Carriquiriborde, P; Elorriaga, Y; Marino, DJ; Ronco, AE	1
Krysiak, R; Okopień, B	1
Elliott, M; Etherson, K; Halbert, G	2
Budzinski, H; Choubert, JM; Coquery, M; Miège, C; Pomiès, M; Wisniewski, C	1
Hegazy, MA	1
Ding, T; Li, J; Wang, S; Yang, B	1
Bai, X; Huang, Z; Li, Q; Lin, X; Zhu, Y	1
Corvini, PF; Demaria, F; Kolvenbach, BA; Suleiman, M; Zimmardi, C	1

Reviews

1 review(s) available for ibuprofen and atenolol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

41 other study(ies) available for ibuprofen and atenolol

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. Journal of medicinal chemistry, 2001, Mar-15, Volume: 44, Issue:6 Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water	2001
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk). Journal of medicinal chemistry, 2005, May-05, Volume: 48, Issue:9 Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds. Bioorganic & medicinal chemistry, 2007, Nov-15, Volume: 15, Issue:22 Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Characterization of the drug binding specificity of rat liver fatty acid binding protein. Journal of medicinal chemistry, 2008, Jul-10, Volume: 51, Issue:13 Topics: Anilino Naphthalenesulfonates; Animals; Fatty Acid-Binding Proteins; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Fluorescence; Substrate Specificity	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data. European journal of medicinal chemistry, 2009, Volume: 44, Issue:11 Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution	2009
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. Bioorganic & medicinal chemistry, 2009, Oct-01, Volume: 17, Issue:19 Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability? Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9 Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR. European journal of medicinal chemistry, 2011, Volume: 46, Issue:1 Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics	2011
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics. PloS one, 2016, Volume: 11, Issue:10 Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat	2016
More commonly prescribed medications. Dental management, 1988, Volume: 28, Issue:6 Topics: Alprazolam; Atenolol; Dental Care; Drug Therapy; Furosemide; Humans; Ibuprofen; Propranolol	1988
Mechanisms of melatonin inhibition of neurohypophysial hormone release from the rat hypothalamus in vitro. Brain research bulletin, 1998, Volume: 45, Issue:1 Topics: Animals; Atenolol; Atropine; Haloperidol; Hypothalamus; Ibuprofen; In Vitro Techniques; Male; Mecamylamine; Melatonin; Naloxone; Oxytocin; Phentolamine; Rats; Rats, Wistar; Receptors, Neurotransmitter; Reproducibility of Results; Vasopressins	1998
Direct injection of large volumes of plasma/serum on a new biocompatible extraction column for the determination of atenolol, propranolol and ibuprofen. Mechanisms for the improvement of chromatographic performance. Journal of chromatography. A, 1998, Feb-27, Volume: 797, Issue:1-2 Topics: Adrenergic beta-Antagonists; Analgesics, Non-Narcotic; Atenolol; Biocompatible Materials; Chromatography, High Pressure Liquid; Humans; Ibuprofen; Indicators and Reagents; Propranolol; Reproducibility of Results; Solvents; Spectrophotometry, Ultraviolet	1998
[Two complex suicidal poisonings with drugs and their medicolegal aspects]. Przeglad lekarski, 2001, Volume: 58, Issue:4 Topics: Adult; Atenolol; Chromatography, High Pressure Liquid; Diclofenac; Estazolam; Fatal Outcome; Female; Humans; Ibuprofen; Illicit Drugs; Ketoprofen; Male; Metronidazole; Naproxen; Poland; Suicide, Attempted; Theophylline; Tolperisone	2001
Determination of enantiomeric compositions of pharmaceutical products by near-infrared spectrometry. Analytical biochemistry, 2004, Feb-15, Volume: 325, Issue:2 Topics: alpha-Cyclodextrins; Atenolol; Ibuprofen; Isomerism; Pharmaceutical Preparations; Propranolol; Spectroscopy, Near-Infrared; Water	2004
Oxidative transformation of micropollutants during municipal wastewater treatment: comparison of kinetic aspects of selective (chlorine, chlorine dioxide, ferrate VI, and ozone) and non-selective oxidants (hydroxyl radical). Water research, 2010, Volume: 44, Issue:2 Topics: Ammonia; Atenolol; Bromides; Carbamazepine; Chlorine; Chlorine Compounds; Efficiency; Ethinyl Estradiol; Fresh Water; Hydroxyl Radical; Ibuprofen; Iron; Kinetics; Nitrites; Organic Chemicals; Oxidants; Oxidation-Reduction; Oxides; Ozone; Sulfamethoxazole; Waste Disposal, Fluid; Water Pollutants, Chemical	2010
Emerging pollutants in sewage, surface and drinking water in Galicia (NW Spain). Chemosphere, 2012, Volume: 86, Issue:10 Topics: Atenolol; Benzophenones; Diclofenac; Drinking Water; Environmental Monitoring; Flame Retardants; Ibuprofen; Insecticides; Naproxen; Organophosphates; Plasticizers; Salicylic Acid; Seasons; Sewage; Spain; Sunscreening Agents; Triclosan; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Pollution, Chemical	2012
Drug permeability prediction using PMF method. Journal of molecular modeling, 2013, Volume: 19, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Antihypertensive Agents; Atenolol; Caco-2 Cells; Cell Line; Cell Membrane; Cell Membrane Permeability; Doxorubicin; Humans; Ibuprofen; Molecular Dynamics Simulation; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Thermodynamics	2013
Human pharmaceuticals in wastewaters from urbanized areas of Argentina. Bulletin of environmental contamination and toxicology, 2013, Volume: 90, Issue:4 Topics: Argentina; Atenolol; Caffeine; Carbamazepine; Chromatography, High Pressure Liquid; Cities; Diclofenac; Environmental Monitoring; Humans; Ibuprofen; Mass Spectrometry; Pharmaceutical Preparations; Wastewater; Water Pollutants, Chemical	2013
[Drug-induced exacerbation of hypoaldosteronism in autoimmune polyglandular syndrome type 2]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:4 Topics: Adult; Atenolol; Female; Fludrocortisone; Humans; Hypoaldosteronism; Ibuprofen; Mineralocorticoids; Polyendocrinopathies, Autoimmune; Renin	2012
Determination of excipient based solubility increases using the CheqSol method. International journal of pharmaceutics, 2014, Apr-25, Volume: 465, Issue:1-2 Topics: 2-Hydroxypropyl-beta-cyclodextrin; Atenolol; Automation, Laboratory; beta-Cyclodextrins; Chemistry, Pharmaceutical; Excipients; Gliclazide; Hydrogen-Ion Concentration; Ibuprofen; Kinetics; Pharmaceutical Preparations; Poloxamer; Potentiometry; Propranolol; Solubility; Technology, Pharmaceutical	2014
Lab-scale experimental strategy for determining micropollutant partition coefficient and biodegradation constants in activated sludge. Environmental science and pollution research international, 2015, Volume: 22, Issue:6 Topics: Aerobiosis; Anaerobiosis; Atenolol; Biodegradation, Environmental; Carbon; Denitrification; Diclofenac; Fluoxetine; Ibuprofen; Nitrification; Sewage; Wastewater; Water Pollutants, Chemical	2015
A novel pure component contribution algorithm (PCCA) for extracting components' contribution from severely overlapped signals; an application to UV-spectrophotometric data. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2015, Volume: 151 Topics: Acetaminophen; Algorithms; Amiloride; Atenolol; Capsules; Hydrochlorothiazide; Ibuprofen; Spectrophotometry, Ultraviolet; Tablets	2015
The influence of non-ionisable excipients on precipitation parameters measured using the CheqSol method. The Journal of pharmacy and pharmacology, 2016, Volume: 68, Issue:9 Topics: 2-Hydroxypropyl-beta-cyclodextrin; Atenolol; beta-Cyclodextrins; Chemistry, Pharmaceutical; Excipients; Gliclazide; Hydrogen-Ion Concentration; Ibuprofen; Kinetics; Pharmaceutical Solutions; Poloxamer; Propranolol; Solubility; Solutions	2016
Biological removal of pharmaceuticals by Navicula sp. and biotransformation of bezafibrate. Chemosphere, 2020, Volume: 240 Topics: Atenolol; Bezafibrate; Biodegradation, Environmental; Carbamazepine; Diatoms; Fresh Water; Ibuprofen; Inactivation, Metabolic; Naproxen; Pharmaceutical Preparations; Sulfamethoxazole; Water Pollutants, Chemical	2020
A super-hydrophilic partially reduced graphene oxide membrane with improved stability and antibacterial properties. Water science and technology : a journal of the International Association on Water Pollution Research, 2022, Volume: 86, Issue:6 Topics: Amlodipine; Anti-Bacterial Agents; Atenolol; Calcium Chloride; Carbamazepine; Chlorides; Graphite; Hydrophobic and Hydrophilic Interactions; Ibuprofen; Membranes, Artificial; Pharmaceutical Preparations; Piperazines; Polyphenols; Salts; Sodium Chloride; Tea; Water	2022
Analyzing microbial communities and their biodegradation of multiple pharmaceuticals in membrane bioreactors. Applied microbiology and biotechnology, 2023, Volume: 107, Issue:17 Topics: Acetaminophen; Atenolol; Biodegradation, Environmental; Bioreactors; Caffeine; Environmental Pollutants; Ibuprofen; Microbiota; Pharmaceutical Preparations; RNA, Ribosomal, 16S; Water Pollutants, Chemical	2023